While no information exists about the neuronal basis of the clinical phenotype in CLS patients, recent findings in mouse and Drosophila gave first insights into the impact of RSK2 on neuronal functions. The gene discussed is RPS6KA3; the disease is Coffin-Lowry syndrome.